125 related articles for article (PubMed ID: 15300426)
1. The impact of comorbidity on the survival of postmenopausal women with breast cancer.
Nagel G; Wedding U; Röhrig B; Katenkamp D
J Cancer Res Clin Oncol; 2004 Nov; 130(11):664-70. PubMed ID: 15300426
[TBL] [Abstract][Full Text] [Related]
2. Impact of acquired comorbidities on all-cause mortality rates among older breast cancer survivors.
Ahern TP; Lash TL; Thwin SS; Silliman RA
Med Care; 2009 Jan; 47(1):73-9. PubMed ID: 19106734
[TBL] [Abstract][Full Text] [Related]
3. General and abdominal obesity and survival among young women with breast cancer.
Abrahamson PE; Gammon MD; Lund MJ; Flagg EW; Porter PL; Stevens J; Swanson CA; Brinton LA; Eley JW; Coates RJ
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1871-7. PubMed ID: 17035393
[TBL] [Abstract][Full Text] [Related]
4. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
5. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials.
Neuhouser ML; Aragaki AK; Prentice RL; Manson JE; Chlebowski R; Carty CL; Ochs-Balcom HM; Thomson CA; Caan BJ; Tinker LF; Urrutia RP; Knudtson J; Anderson GL
JAMA Oncol; 2015 Aug; 1(5):611-21. PubMed ID: 26182172
[TBL] [Abstract][Full Text] [Related]
6. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990-2008.
Land LH; Dalton SO; Jensen MB; Ewertz M
Breast Cancer Res Treat; 2012 Feb; 131(3):1013-20. PubMed ID: 22002567
[TBL] [Abstract][Full Text] [Related]
7. Smoking and mortality after breast cancer diagnosis: the health and functioning in women study.
Izano M; Satariano WA; Hiatt RA; Braithwaite D
Cancer Med; 2015 Feb; 4(2):315-24. PubMed ID: 25511535
[TBL] [Abstract][Full Text] [Related]
8. Weight gain prior to diagnosis and survival from breast cancer.
Cleveland RJ; Eng SM; Abrahamson PE; Britton JA; Teitelbaum SL; Neugut AI; Gammon MD
Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1803-11. PubMed ID: 17855698
[TBL] [Abstract][Full Text] [Related]
9. Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor-positive breast cancer.
van de Water W; Markopoulos C; van de Velde CJ; Seynaeve C; Hasenburg A; Rea D; Putter H; Nortier JW; de Craen AJ; Hille ET; Bastiaannet E; Hadji P; Westendorp RG; Liefers GJ; Jones SE
JAMA; 2012 Feb; 307(6):590-7. PubMed ID: 22318280
[TBL] [Abstract][Full Text] [Related]
10. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005.
Cronin-Fenton DP; Nørgaard M; Jacobsen J; Garne JP; Ewertz M; Lash TL; Sørensen HT
Br J Cancer; 2007 May; 96(9):1462-8. PubMed ID: 17406360
[TBL] [Abstract][Full Text] [Related]
11. Obesity and outcomes in premenopausal and postmenopausal breast cancer.
Loi S; Milne RL; Friedlander ML; McCredie MR; Giles GG; Hopper JL; Phillips KA
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1686-91. PubMed ID: 16030102
[TBL] [Abstract][Full Text] [Related]
12. Dietary fat, fiber, vegetable, and micronutrients are associated with overall survival in postmenopausal women diagnosed with breast cancer.
McEligot AJ; Largent J; Ziogas A; Peel D; Anton-Culver H
Nutr Cancer; 2006; 55(2):132-40. PubMed ID: 17044767
[TBL] [Abstract][Full Text] [Related]
13. A comprehensive prognostic index to predict survival based on multiple comorbidities: a focus on breast cancer.
Fleming ST; Rastogi A; Dmitrienko A; Johnson KD
Med Care; 1999 Jun; 37(6):601-14. PubMed ID: 10386572
[TBL] [Abstract][Full Text] [Related]
14. Active and passive cigarette smoke and breast cancer survival.
Sagiv SK; Gaudet MM; Eng SM; Abrahamson PE; Shantakumar S; Teitelbaum SL; Britton JA; Bell P; Thomas JA; Neugut AI; Santella RM; Gammon MD
Ann Epidemiol; 2007 May; 17(5):385-93. PubMed ID: 17395485
[TBL] [Abstract][Full Text] [Related]
15. Stage at diagnosis and comorbidity influence breast cancer survival in First Nations women in Ontario, Canada.
Sheppard AJ; Chiarelli AM; Marrett LD; Nishri ED; Trudeau ME
Cancer Epidemiol Biomarkers Prev; 2011 Oct; 20(10):2160-7. PubMed ID: 21803843
[TBL] [Abstract][Full Text] [Related]
16. Impact of comorbidity on outcome of older breast cancer patients: a FOCUS cohort study.
Kiderlen M; de Glas NA; Bastiaannet E; van de Water W; de Craen AJ; Guicherit OR; Merkus JW; Extermann M; van de Velde CJ; Liefers GJ
Breast Cancer Res Treat; 2014 May; 145(1):185-92. PubMed ID: 24676624
[TBL] [Abstract][Full Text] [Related]
17. Relative mortality rates from incident chronic diseases among breast cancer survivors--a 14 year follow-up of five-year survivors diagnosed in Denmark between 1994 and 2007.
Ording AG; Boffetta P; Garne JP; Nyström PM; Cronin-Fenton D; Frøslev T; Silliman R; Sørensen HT; Lash TL
Eur J Cancer; 2015 Apr; 51(6):767-75. PubMed ID: 25765753
[TBL] [Abstract][Full Text] [Related]
18. S4646 polymorphism in CYP19A1 gene is associated with the efficacy of hormone therapy in early breast cancer.
Shao X; Cai J; Zheng Y; Wang J; Feng J; Huang Y; Shi L; Chen Z; Guo Y; Wang X
Int J Clin Exp Pathol; 2015; 8(5):5309-17. PubMed ID: 26191232
[TBL] [Abstract][Full Text] [Related]
19. Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
Birim O; Kappetein AP; Bogers AJ
Eur J Cardiothorac Surg; 2005 Nov; 28(5):759-62. PubMed ID: 16157485
[TBL] [Abstract][Full Text] [Related]
20. Carpal tunnel syndrome and musculoskeletal symptoms in postmenopausal women with early breast cancer treated with exemestane or tamoxifen after 2-3 years of tamoxifen: a retrospective analysis of the Intergroup Exemestane Study.
Mieog JS; Morden JP; Bliss JM; Coombes RC; van de Velde CJ;
Lancet Oncol; 2012 Apr; 13(4):420-32. PubMed ID: 22265698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
